Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Drug therapies in bronchopulmonary dysplasia: debunking the myths.

Tin W, Wiswell TE.

Semin Fetal Neonatal Med. 2009 Dec;14(6):383-90. doi: 10.1016/j.siny.2009.08.003. Epub 2009 Sep 10. Review.

PMID:
19747890
2.

Adjunctive therapies in chronic lung disease: examining the evidence.

Tin W, Wiswell TE.

Semin Fetal Neonatal Med. 2008 Feb;13(1):44-52. Epub 2007 Nov 5. Review.

PMID:
17983879
3.

Bronchopulmonary dysplasia.

Deakins KM.

Respir Care. 2009 Sep;54(9):1252-62.

4.

Current therapy of bronchopulmonary dysplasia.

Rush MG, Hazinski TA.

Clin Perinatol. 1992 Sep;19(3):563-90. Review.

PMID:
1526072
5.

[From classic to new bronchopulmonary dysplasia].

Kramer BW, Lievense S, Been JV, Zimmermann LJ.

Ned Tijdschr Geneeskd. 2010;154:A1024. Review. Dutch.

PMID:
20456770
6.

Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

D'Angio CT, Maniscalco WM.

Paediatr Drugs. 2004;6(5):303-30.

PMID:
15449969
7.

Rationale for antioxidant therapy in premature infants to prevent bronchopulmonary dysplasia.

Welty SE, Smith CV.

Nutr Rev. 2001 Jan;59(1 Pt 1):10-7. Review.

PMID:
11281247
8.

Impact of lung surfactant therapy on chronic lung diseases in premature infants.

Hudak BB, Egan EA.

Clin Perinatol. 1992 Sep;19(3):591-602. Review.

PMID:
1526073
9.
10.

An update on pharmacologic approaches to bronchopulmonary dysplasia.

Ghanta S, Leeman KT, Christou H.

Semin Perinatol. 2013 Apr;37(2):115-23. doi: 10.1053/j.semperi.2013.01.008. Review.

11.

[Bronchopulmonary dysplasia].

Clément A.

Rev Mal Respir. 1996 Jul;13(3):243-9. Review. French.

PMID:
8765916
12.

Summary proceedings from the bronchopulmonary dysplasia group.

Walsh MC, Szefler S, Davis J, Allen M, Van Marter L, Abman S, Blackmon L, Jobe A.

Pediatrics. 2006 Mar;117(3 Pt 2):S52-6.

PMID:
16777823
13.

Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia.

Ambalavanan N, Carlo WA.

Semin Perinatol. 2006 Aug;30(4):192-9. Review.

PMID:
16860159
14.

Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia--what is the evidence?

Thomas W, Speer CP.

Neonatology. 2008;94(3):150-9. doi: 10.1159/000143719. Epub 2008 Aug 1. Review.

PMID:
18679037
15.

Changes in the pathogenesis and prevention of chronic lung disease of prematurity.

Bancalari E.

Am J Perinatol. 2001;18(1):1-9. Review.

PMID:
11321240
16.

Pathogenesis of bronchopulmonary dysplasia.

Chess PR, D'Angio CT, Pryhuber GS, Maniscalco WM.

Semin Perinatol. 2006 Aug;30(4):171-8. Review.

PMID:
16860156
17.

Pharmacological strategies in the prevention and management of bronchopulmonary dysplasia.

Baveja R, Christou H.

Semin Perinatol. 2006 Aug;30(4):209-18. Review.

PMID:
16860161
18.

Emerging drugs for the prevention of bronchopulmonary dysplasia.

Greenough A.

Expert Opin Emerg Drugs. 2008 Sep;13(3):537-46. doi: 10.1517/14728214.13.3.537 . Review.

PMID:
18764728
19.

Pathogenesis of bronchopulmonary dysplasia.

Hayes D Jr, Feola DJ, Murphy BS, Shook LA, Ballard HO.

Respiration. 2010;79(5):425-36. doi: 10.1159/000242497. Epub 2009 Sep 25. Review.

PMID:
19786727
20.

Predisposition of infants with chronic lung disease to respiratory syncytial virus-induced respiratory failure: a vascular hypothesis.

Carpenter TC, Stenmark KR.

Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S33-40. Review.

PMID:
14730268

Supplemental Content

Support Center